Mid-Year Report

DALRYMPLE & ASSOCIATES, LLC for EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION)

Firm
Client
Income
$100,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

Defense authorization and appropriations legislation, MILVAX Program, Biodefense and biological product acquisition and R&D issues

LobbyistCovered position, as disclosed
DONALD DALRYMPLE PRINCIPAL

Contacted: HOUSE OF REPRESENTATIVES; Homeland Security, Dept of (DHS); SENATE; Defense, Dept of (DOD); White House Office; Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS)

Health Issues HCR

Project BioShield, Biodefense vaccine and biological product R&D, procurement for the Strategic National Stockpile, and product liability related oversight, authorizing, and appropriations legislation; DHHS and CDC procurement of anthrax vaccines

LobbyistCovered position, as disclosed
DONALD DALRYMPLE PRINCIPAL

Contacted: Health & Human Services, Dept of (HHS); Homeland Security, Dept of (DHS); Food & Drug Administration (FDA); Defense, Dept of (DOD); SENATE; HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); White House Office

Homeland Security HOM

Project BioShield and bioterrorism preparedness authorization and appropriatons legislation and related oversight issues

LobbyistCovered position, as disclosed
DONALD DALRYMPLE PRINCIPAL

Contacted: Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; White House Office; Food & Drug Administration (FDA); Homeland Security, Dept of (DHS); SENATE; Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS)

Medical/Disease Research/Clinical Labs MED

Biodefense R&D Vaccine and Biological Product funding

LobbyistCovered position, as disclosed
DONALD DALRYMPLE PRINCIPAL

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Disease Control & Prevention (CDC); Defense, Dept of (DOD); Food & Drug Administration (FDA); Homeland Security, Dept of (DHS); Health & Human Services, Dept of (HHS); White House Office

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.